• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAstraZeneca

AstraZeneca

A robot arm from ABB on display at Automatica 2023 in Munich. (Photo: Sven Hoppe/dpa/Getty Images)
Newsletters
SoftBank will acquire ABB’s robotics business
By Andrew NuscaOctober 9, 2025
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
Politics
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
By AFPJuly 22, 2025
U.K. business leaders are ‘struggling to see what’s business-friendly’ about Labour
Politics
U.K. business leaders are ‘struggling to see what’s business-friendly’ about Labour
By Jamie Nimmo, Irina Anghel, Jennifer Creery and BloombergJuly 7, 2025
New London IPOs hit 28-year low amid AstraZeneca exit concerns
Economy
New London IPOs hit 28-year low amid AstraZeneca exit concerns
By Pablo Mayo Cerqueiro, Joe Easton, Neil Campling and BloombergJuly 3, 2025
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
Finance
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
By AFPApril 29, 2025
AstraZeneca to buy cell therapy biotech for up to $1 billion
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By Ashleigh Furlong and BloombergMarch 17, 2025
AstraZeneca sees profits surge despite Chinese import tax allegations
Health
AstraZeneca sees profits surge despite Chinese import tax allegations
By AFPFebruary 6, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
Ryanair ceo Michael O'Leary sitting by a table
Success
Ryanair’s Michael O’Leary, who is up for a $108 million bonus, doesn’t see high CEO pay as a problem: ‘Footballers are getting half a million a week’
By Prarthana PrakashJanuary 10, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
Retail
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
By AFPNovember 12, 2024
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
Leadership
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By AFPNovember 7, 2024
AstraZeneca’s drive for China dominance in focus as chief probed
Finance
AstraZeneca’s drive for China dominance in focus as chief probed
By Amber Tong and BloombergOctober 31, 2024
Pascal Soriot, chief executive officer of AstraZeneca Plc.
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By Ashleigh Furlong and BloombergMay 21, 2024
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Health
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
By The Associated PressMay 9, 2024
1
  • 1
  • 2
  • 3
  • 4
  • 5
...13
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.